Directorio

We are doing this study to find out if an experimental drug and device system called X-PACT is a safe and effective treatment for various forms of cancer.

We are doing this study to find out if an experimental drug called XmAb819 (the study drug) is a safe and effective treatment for clear cell renal cell carcinoma (ccRCC).

We are doing this study to learn how to get the best quality images of lungs in an MRI scanner as people breathe in Xenon gas. We hope this imaging will show key differences between diseased and healthy lungs.

We are doing this study to find out if an experimental drug called XTX101 (the study drug) is a safe and effective option for people who have advanced tumors or metastatic microsatellite stable colorectal cancer. We want to see how well it works on its own and in combination with a drug called atezolizumab.

We are doing this study to find out if the XVIVO Heart Preservation System (the study device) is a safe and effective technology that can preserve and maintain extended criteria donor hearts for transplantation.

We are doing this study to find the safest and most effective dose of an experimental drug called ZL-1310 (the study drug). We want to know if this drug can be beneficial for people with small cell lung cancer (SCLC) that progressed after at least one round of chemotherapy.

We are doing this study to find the most effective, safe dose of an experimental drug called zanzalintinib (the study drug). We want to know how well it works in combination with pembrolizumab when it is given to people who have recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

We are doing this study to find out what the safest and most effective dose of the study drug (ZN-A-1041) is when given alone or in combination with Capecitabine.